•
Mar 31, 2023

Philip Morris Q1 2023 Earnings Report

Reported diluted EPS of $1.28 and adjusted diluted EPS of $1.38, exceeding expectations.

Key Takeaways

Philip Morris International's Q1 2023 results show a strong performance with adjusted diluted EPS of $1.38, exceeding expectations. Net revenues increased by 3.5% on a reported basis and 3.2% organically. The integration of Swedish Match contributed positively, and the company is reaffirming its full-year 2023 forecast for organic net revenue growth and currency-neutral adjusted diluted EPS growth.

Reported net revenues up by 9.6%, excluding currency.

Combustible tobacco net revenue decline of 1.5%; growth of 3.0% on an organic basis, driven by pricing of 7.4%.

Market share for HTUs in IQOS markets up by 0.9 points to 9.0%.

ZYN nicotine pouch (NP) shipment volume in the U.S. of 73.2 million cans, representing growth of 46.7% versus first-quarter 2022 Swedish Match shipments of 49.9 million cans

Total Revenue
$8.02B
Previous year: $7.75B
+3.5%
EPS
$1.38
Previous year: $1.56
-11.5%
Gross Profit
$5B
Previous year: $5.16B
-3.2%
Cash and Equivalents
$2.43B
Previous year: $4.62B
-47.5%
Free Cash Flow
-$1.23B
Previous year: $889M
-238.8%
Total Assets
$62.1B
Previous year: $41.7B
+48.7%

Philip Morris

Philip Morris

Forward Guidance

The company is reaffirming its full-year 2023 forecast for organic net revenue growth of 7% to 8.5% and currency-neutral adjusted diluted EPS growth of 7% to 9%.

Positive Outlook

  • An estimated total international industry volume decline for cigarettes and HTUs, excluding China and the U.S., of 1% to 2%.
  • A total cigarette and HTU shipment volume change for PMI of approximately flat to +1%.
  • HTU shipment volume of 125 to 130 billion units, broadly in line with anticipated adjusted in-market sales volume and reflecting an acceleration in growth versus 2022.
  • Net revenue growth of approximately 7% to 8.5% on an organic basis.
  • Strong full-year performance for Swedish Match’s existing operations, underpinned by strong shipment volume growth for ZYN in the U.S.

Challenges Ahead

  • A cigarette shipment volume decline of approximately 2.5% to 3.5%.
  • An adjusted operating income margin decline of 50 to 150 basis points on an organic basis, primarily reflecting continued global inflationary pressures.
  • Wellness and Healthcare segment net revenues of around $300 million (including smoking cessation products), with an adjusted operating loss of around $150 million, primarily due to investments in research and development.
  • Incremental net interest costs of around $200 million versus 2022 on PMI borrowings excluding Swedish Match-related financing, notably reflecting higher borrowing costs on refinanced debt.
  • No share repurchases in 2023.